Javascript must be enabled to continue!
AlphaDesign: A de novo protein design framework based on AlphaFold
View through CrossRef
De novo
protein design is a longstanding fundamental goal of synthetic biology, but has been hindered by the difficulty in reliable prediction of accurate high-resolution protein structures from sequence. Recent advances in the accuracy of protein structure prediction methods, such as AlphaFold (AF), have facilitated proteome scale structural predictions of monomeric proteins. Here we develop AlphaDesign, a computational framework for
de novo
protein design that embeds AF as an oracle within an optimisable design process. Our framework enables rapid prediction of completely novel protein monomers starting from random sequences. These are shown to adopt a diverse array of folds within the known protein space. A recent and unexpected utility of AF to predict the structure of protein complexes, further allows our framework to design higher-order complexes. Subsequently a range of predictions are made for monomers, homodimers, heterodimers as well as higher-order homo-oligomers - trimers to hexamers. Our analyses also show potential for designing proteins that bind to a pre-specified target protein. Structural integrity of predicted structures is validated and confirmed by standard
ab initio
folding and structural analysis methods as well as more extensively by performing rigorous all-atom molecular dynamics simulations and analysing the corresponding structural flexibility, intramonomer and interfacial amino-acid contacts. These analyses demonstrate widespread maintenance of structural integrity and suggests that our framework allows for fairly accurate protein design. Strikingly, our approach also reveals the capacity of AF to predict proteins that switch conformation upon complex formation, such as involving switches from
α
-helices to
β
-sheets during amyloid filament formation. Correspondingly, when integrated into our design framework, our approach reveals
de novo
design of a subset of proteins that switch conformation between monomeric and oligomeric state.
Title: AlphaDesign: A
de novo
protein design framework based on AlphaFold
Description:
De novo
protein design is a longstanding fundamental goal of synthetic biology, but has been hindered by the difficulty in reliable prediction of accurate high-resolution protein structures from sequence.
Recent advances in the accuracy of protein structure prediction methods, such as AlphaFold (AF), have facilitated proteome scale structural predictions of monomeric proteins.
Here we develop AlphaDesign, a computational framework for
de novo
protein design that embeds AF as an oracle within an optimisable design process.
Our framework enables rapid prediction of completely novel protein monomers starting from random sequences.
These are shown to adopt a diverse array of folds within the known protein space.
A recent and unexpected utility of AF to predict the structure of protein complexes, further allows our framework to design higher-order complexes.
Subsequently a range of predictions are made for monomers, homodimers, heterodimers as well as higher-order homo-oligomers - trimers to hexamers.
Our analyses also show potential for designing proteins that bind to a pre-specified target protein.
Structural integrity of predicted structures is validated and confirmed by standard
ab initio
folding and structural analysis methods as well as more extensively by performing rigorous all-atom molecular dynamics simulations and analysing the corresponding structural flexibility, intramonomer and interfacial amino-acid contacts.
These analyses demonstrate widespread maintenance of structural integrity and suggests that our framework allows for fairly accurate protein design.
Strikingly, our approach also reveals the capacity of AF to predict proteins that switch conformation upon complex formation, such as involving switches from
α
-helices to
β
-sheets during amyloid filament formation.
Correspondingly, when integrated into our design framework, our approach reveals
de novo
design of a subset of proteins that switch conformation between monomeric and oligomeric state.
Related Results
Assessment of AlphaFold structures and optimization methods for virtual screening
Assessment of AlphaFold structures and optimization methods for virtual screening
AbstractRecent advancements in artificial intelligence such as AlphaFold, have enabled more accurate prediction of protein three-dimensional structure from amino acid sequences. Th...
Applications of AlphaFold beyond Protein Structure Prediction
Applications of AlphaFold beyond Protein Structure Prediction
AbstractPredicting structures accurately for natural protein sequences by DeepMind’s AlphaFold is certainly one of the greatest breakthroughs in biology in the twenty-first century...
Endothelial Protein C Receptor
Endothelial Protein C Receptor
IntroductionThe protein C anticoagulant pathway plays a critical role in the negative regulation of the blood clotting response. The pathway is triggered by thrombin, which allows ...
Design of Cyclic Peptides Targeting Protein-Protein Interactions using AlphaFold
Design of Cyclic Peptides Targeting Protein-Protein Interactions using AlphaFold
Abstract
More than 930,000 protein-protein interactions (PPIs) have been identified in recent years, but their physicochemical properties differ from conventional d...
12481 Evaluating The Device Handling And Preference Assessment Questionnaire For Growth Hormone Deficiency: Results From Content Validation Interviews
12481 Evaluating The Device Handling And Preference Assessment Questionnaire For Growth Hormone Deficiency: Results From Content Validation Interviews
Abstract
Disclosure: J. Neergaard: Employee; Self; Novo Nordisk. S. Akhtar: Employee; Self; Novo Nordisk. Stock Owner; Self; Novo Nordisk. B. Berg: Employee; Self; N...
1651-P: Elevated FGF21 Levels after Total Pancreatectomy and in Response to Single-Dose Glucagon Receptor Antagonism in Humans
1651-P: Elevated FGF21 Levels after Total Pancreatectomy and in Response to Single-Dose Glucagon Receptor Antagonism in Humans
Fibroblast growth factor 21 (FGF21) is a liver-secreted peptide hormone reportedly improving metabolic homeostasis, partly via reduced hunger for sugar, fat, protein and alcohol. E...
Solubility-aware protein binding peptide design using AlphaFold
Solubility-aware protein binding peptide design using AlphaFold
Abstract
New protein–protein interactions (PPIs) are being identified, but PPIs have different physicochemical properties compared with conventional targets, making...

